3
Announcements
Trials
Browse
Landscape
Status
Unknown
2
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Plasma cell
2
Conditions
Multiple Myeloma
2
Inflammation
1
Fatigue
1
Interventions
Dexamethasone
64
Cyclophosphamide
40
Bortezomib
37
Melphalan
24
Lenalidomide
23
Thalidomide
17
pomalidomide
16
fludarabine
12
daratumumab
11
carfilzomib
10
Filgrastim
8
Doxorubicin
8
Busulfan
6
Prednisone
5
Peripheral Blood Stem Cell Transplantation
5
Bendamustine Hydrochloride
5
selinexor
4
sargramostim
4
isatuximab
4
fludarabine phosphate
4
Surveys and Questionnaires
4
Etoposide
4
Clarithromycin
4
Calcium Dobesilate
4
liposomal doxorubicin
3
ixazomib
3
Radiotherapy
3
Neoadjuvant Therapy
3
Mycophenolic Acid
3
Methylprednisolone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Multiple Myeloma
×
Chromatin Immunoprecipitation Sequencing
×
Clear all
NCT05888636
2024-03-22
TEDROMM
Regina Elena Cancer Institute
Unknown
200 enrolled
NCT05858203
2023-05-15
AATF/Che-1
Regina Elena Cancer Institute
Unknown
150 enrolled